Issue 1, 2009
From the journal:

Molecular BioSystems

The prospects of glycanbiomarkers for the diagnosis of diseases

Carlito B. Lebrilla*a  and  Hyun Joo Ana  

* Corresponding authors

a Department of Chemistry and Department of Biochemistry and Molecular Medicine, University of California, Davis, USA
E-mail: cblebrilla@ucdavis.edu
Fax: +1–530–752–8995
Tel: +1–530–752–6364

Abstract

Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.

Graphical abstract: The prospects of glycanbiomarkers for the diagnosis of diseases

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/B811781K
Article type
Opinion
First published
06 Nov 2008

Mol. BioSyst., 2009,5, 17-20

Permissions

Request permissions

The prospects of glycanbiomarkers for the diagnosis of diseases

C. B. Lebrilla and H. J. An, Mol. BioSyst., 2009, 5, 17 DOI: 10.1039/B811781K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements